PTEN and cancer: Contradictory findings have been reported in B-ALL where CK2α, frequently overexpressed and hyperactivated in all cancers including leukemia, phosphorylates PTEN at its C-terminal leading to its stabilization with simultaneous inhibition of its activity [91,92,93].